Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
MUC5B encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. Additionally we are shipping MUC5B Kits (38) and MUC5B Proteins (11) and many more products for this protein.
Showing 10 out of 85 products:
Human Polyclonal MUC5B Primary Antibody for IF (p), IHC (p) - ABIN739920
Fields, Song, Rasoul, Fong, Works, Shew, Yiu, Mirsalis, DAndrea: New candidate biomarkers in the female genital tract to evaluate microbicide toxicity. in PLoS ONE 2014
Show all 2 references for ABIN739920
Both compounds down regulated mucin (show SLC13A2 Antibodies) 5 subtype B, and peptidoglycan recognition protein 1 (show PGLYRP1 Antibodies) in vaginal tissue
Expressions of Orai1 (show TMEM132A Antibodies), Muc5b, IL-4 (show IL4 Antibodies), IL-5 (show IL5 Antibodies), IL-13 (show IL13 Antibodies) and IL-33 (show IL33 Antibodies) were up-regulated in the allergic state and IL-33 (show IL33 Antibodies) increased the levels of Muc5b, IL-4 (show IL4 Antibodies), IL-5 (show IL5 Antibodies) and IL-13 (show IL13 Antibodies), but did not influence proliferation of T cells.
deleting either the Muc5ac or Muc5b gene is insufficient to create an observable dry eye phenotype on the ocular surface of these mice.
mouse Muc5b (but not Muc5ac) is required for mucociliary clearance, for controlling infections in the airways and middle ear, and for maintaining immune homeostasis in mouse lungs, whereas Muc5ac is dispensable
Muc5b was detected in all mammary tumors analyzed from MMTV-ras mice
Muc5b is a target gene of transcription factors (TTF-1 (show NKX2-1 Antibodies), GATA-6 (show GATA6 Antibodies)) involved in lung differentiation programs during development and carcinogenesis. TTF-1 (show NKX2-1 Antibodies) is a strong repressor of Muc5b.
analysis of Muc5ac and Muc5b production during prenatal and postnatal murine lung development
Acidic pH drives middle ear epithelial Muc5b gene expression in vitro, which perhaps explains how laryngopharyngeal reflux can contribute to otitis media.
The isolation and characterization of the mouse Muc5b mucin (show SLC13A2 Antibodies) gene (mMuc5b), determined its complete cDNA sequence, its genomic organization, and chromosomal localization and expression.
C-mannosylation is likely required for proper folding of the Cys (show DNAJC5 Antibodies) subdomains and/or for some aspect of ER export during mucin (show SLC13A2 Antibodies) biosynthesis
MUC5B was significantly more often detected in middle ear effusion fluid relative to MUC5AC. MUC5B presence was statistically associated with mucoid effusions relative to serous effusions.
Results collectively indicate unique links between dual-specificity phosphatase 28 (DUSP28) and mucins MUC5B/MUC16 and their roles in pancreatic cancer.
Study provides evidence showing that MUC5B expression in cancer cells contributes to certain tumorigenic properties of breast cancer cells, such as cell growth, adhesion, clonogenic ability and drug chemo-resistance.
this study shows that histamine activated the NF-kappaB (show NFKB1 Antibodies) pathway, contributing to MUC5B overproduction and secretion in nasal epithelial cells
This study showed that MUC5B minor allele predisposes to poradic idiopathic pulmonary fi brosis (spIPF), familial interstitial pneumonia (FIP (show USF2 Antibodies)) and idiopathic non-speci fi c interstitial pneumonia. In spIPF, survival is not in fl uenced by MUC5B alleles. In FIP (show USF2 Antibodies), MUC5B minor allele predicts better survival.
MUC5B may play a role in the development of pediatric fibrotic lung disease in patients with Surfactant Protein C (show SFTPC Antibodies) mutations
the MUC5B polymorphism rs35705950 is associated with increased risk of idiopathic pulmonary fibrosis susceptibility, severity, and the decreased overall survival.
The MUC5B promoter polymorphism is the strongest and the most replicated genetic risk factor for Idiopathic pulmonary fibrosis. It is involved in disease pathogenesis through an increase in MUC5B expression in terminal bronchi and honeycombed cysts.
We propose a mechanism whereby MUC5B decreases surface tension lowering capacity of alveolar surfactant at areas with maximal mechanical stress
These results suggest that MUC5B production can be regulated by ECM (show MMRN1 Antibodies) components and that MUC5B is upregulated by fibronectin (show FN1 Antibodies) and laminin via the integrin, ERK (show EPHB2 Antibodies), and NF-kappaB (show NFKB1 Antibodies) dependent pathway.
This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases.
cervical mucin MUC5B
, high molecular weight salivary mucin MG1
, mucin 5, subtype B, tracheobronchial
, sublingual gland mucin
, ovomucin, alpha-subunit